What question did this study set out to answer?

To explore the activation of the renin-angiotensin-aldosterone system in advanced proliferative vitreoretinopathy and its impact on disease progression.

March 28, 2026

View Full Paper

Investigating Renin-Angiotensin-Aldosterone System Activation in Proliferative Vitreoretinopathy: Elevated Vitreous Angiotensin-Converting Enzyme Levels in Advanced Retinal Detachment

BABegüm AydınerTurkish Armed Forces MÇMehmet ÇıtırıkTurkish Armed Forces

Key Points

To explore the activation of the renin-angiotensin-aldosterone system in advanced proliferative vitreoretinopathy and its impact on disease progression.
Measured vitreous angiotensin-converting enzyme (ACE) levels in advanced cases of proliferative vitreoretinopathy (PVR)
Compared ACE levels with disease severity
Analyzed potential for RAAS modulation as a treatment strategy.
ACE levels were significantly elevated in patients with advanced PVR
Elevated ACE suggests a possible local role of RAAS in PVR progression
Findings indicate a need for further investigation into RAAS modulation therapies.

Abstract

The significant elevation of ACE in advanced PVR cases suggests a potential role for local RAAS activation in disease progression. These findings support further investigations of RAAS modulation as a candidate for therapeutic intervention in PVR.

AI से पूछें

Bookmark

View Full Paper

AI से पूछें

Bookmark

View Full Paper

Investigating Renin-Angiotensin-Aldosterone System Activation in Proliferative Vitreoretinopathy: Elevated Vitreous Angiotensin-Converting Enzyme Levels in Advanced Retinal Detachment

Key Points

Abstract

Cite This Study